Tag Archives: Regeneron’s

Trump takes Regeneron’s experimental antibodies hours after COVID-19 diagnosis

In a bombshell development Thursday, President Donald J. Trump tested positive for COVID-19, sending shockwaves through the country with just weeks until Election Day. One unanswered question was how the president’s physicians would navigate an uncertain treatment course—and an unproven antibody cocktail from Regeneron is now in the spotlight. Trump’s personal doctor confirmed Friday that the… Read More »

Inside Regeneron’s R&D war room, sleepless nights and ‘esprit de corps’ in hunt for COVID-19 therapy

In a few short weeks, the novel coronavirus pandemic has upturned countries around the world, presenting new and complex workplace challenges. That shift is also true for drugmakers working to combat COVID-19.   For New York-based Regeneron––at the forefront of the COVID-19 hunt––those challenges are unprecedented and extraordinary, but it’s still mostly business as usual.  After… Read More »